Tetra Bio-Pharma’s Evidence-Based Business Model Confirmed
Tetra Bio-Pharma Inc. today announced that the amendment of the Prescription Drug List (PDL) to include phyto-cannabinoids supports its evidence-based business model.
Tetra Bio-Pharma Inc. today announced that the amendment of the Prescription Drug List (PDL) to include phyto-cannabinoids supports its evidence-based business model.